Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | T. Kadia | F. Ravandi | Koichi Takahashi | E. Jabbour | N. Jain | N. Short | W. Wierda | H. Abbas | P. Kebriaei | K. Sasaki | R. Garris | P. Thompson | G. Issa | M. Yilmaz | W. Macaron